Protaphane Hm (Ge) 100 units Suspension for injection
PDF Leaflet Revision Date: 20 Oct 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of Diabetes Mellitus.
Dosage (summary)
Individualized; typically 0.3-1.0 IU/kg/day.
Onset of Action / Duration
Onset: 1.5 hours, Duration: ~24 hours.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safe during pregnancy and breastfeeding; insulin does not cross the placenta.
Key Drug Interactions
- Oral hypoglycaemic agents
- Beta-blockers
- Thiazides
- Glucocorticoids
Contraindications
- Hypoglycaemia
- Hypersensitivity to insulin
Common side effects
- Hypoglycaemia
- Lipodystrophy
- Injection site reactions
Counselling Points
- Rotate injection sites
- Monitor blood glucose regularly
- Carry sugary products for hypoglycaemia
Serious warnings
- Risk of severe hypoglycaemia
- Do not administer intravenously
Important Disclaimer
The Protaphane Hm (Ge) 100 units Suspension for injection professional information leaflet below is the property of Novo Nordisk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
